1. Home
  2. NHC vs IDYA Comparison

NHC vs IDYA Comparison

Compare NHC & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National HealthCare Corporation

NHC

National HealthCare Corporation

N/A

Current Price

$157.09

Market Cap

2.7B

Sector

Health Care

ML Signal

N/A

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

N/A

Current Price

$33.89

Market Cap

2.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NHC
IDYA
Founded
1971
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.9B
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
NHC
IDYA
Price
$157.09
$33.89
Analyst Decision
Strong Buy
Analyst Count
0
16
Target Price
N/A
$51.21
AVG Volume (30 Days)
59.4K
783.9K
Earning Date
06-01-2026
05-19-2026
Dividend Yield
1.62%
N/A
EPS Growth
17.46
61.90
EPS
7.67
N/A
Revenue
$1,517,781,000.00
$218,710,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$213.03
P/E Ratio
$20.61
N/A
Revenue Growth
16.09
3024.43
52 Week Low
$89.14
$13.45
52 Week High
$174.54
$39.28

Technical Indicators

Market Signals
Indicator
NHC
IDYA
Relative Strength Index (RSI) 45.63 53.59
Support Level $153.93 $32.85
Resistance Level $171.64 $36.38
Average True Range (ATR) 6.11 1.31
MACD -1.68 0.33
Stochastic Oscillator 18.98 64.32

Price Performance

Historical Comparison
NHC
IDYA

About NHC National HealthCare Corporation

National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: